GlassScriptPhysician profile
Kenneth Rodriguez
NPI 1912337924
$20,691.18
in general payments reported to CMS, 2019-2025
47 companies · $8,738 in 2025
The $8,738 reported for 2025 was more than what 89% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,419 · 2020: $2,694 · 2021: $640 · 2022: $500 · 2023: $1,489 · 2024: $1,211 · 2025: $8,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,309 · Food and Beverage: $5,200 · Travel and Lodging: $925 · Education: $4.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,308.80 |
| Food and Beverage | $5,199.73 |
| Travel and Lodging | $925.19 |
| Education | $4.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $6,633.24 | 2025 | Mycapssa |
| Sanofi-Aventis U.S. LLC | $4,040.62 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $2,091.79 | 2020-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $1,200.71 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,170.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $476.12 | 2019-2025 | Evenity, Prolia, Repatha |
| Corcept Therapeutics | $428.32 | 2020-2025 | Korlym |
| Genzyme Corporation | $362.00 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $314.35 | 2019-2025 | Jardiance, Synjardy |
| Abbott Laboratories | $282.57 | 2019-2024 | Freestyle Libre 3, Freestyle Libre |
| Abbvie INC. | $281.27 | 2019-2025 | Synthroid |
| Ibsa Pharma INC. | $254.04 | 2020-2025 | Licart, Tirosint, Flector |
| Bayer Healthcare Pharmaceuticals INC. | $241.30 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $240.08 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $203.36 | 2019-2025 | Unithroid |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $203.15 | 2020-2022 | |
| Cequr Corporation | $186.72 | 2025 | Cequr Simplicity |
| Amarin Pharma, INC. | $185.02 | 2019-2020 | |
| Companion Medical, INC. | $183.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $159.85 | 2019-2020 | |
| Antares Pharma, INC. | $155.72 | 2019 | |
| Xeris Pharmaceuticals, INC. | $146.08 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Radius Health, INC. | $143.10 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $139.83 | 2019-2020 | |
| Beta Bionics, INC. | $92.11 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Echosens North America, INC. | $84.34 | 2023 | Fibroscan |
| Mannkind Corporation | $75.28 | 2019 | |
| Shire North American Group INC | $70.88 | 2019 | |
| Kyowa Kirin, INC. | $70.82 | 2023-2024 | Crysvita |
| Rhythm Pharmaceuticals, INC. | $64.77 | 2021-2025 | Imcivree |
| Pfizer INC. | $59.18 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $50.00 | 2019 | |
| Madrigal Pharmaceuticals | $46.31 | 2025 | Rezdiffra |
| Insulet Corporation | $45.43 | 2025 | Omnipod |
| Amphastar Pharmaceuticals, INC. | $45.25 | 2023-2025 | Baqsimi |
| Ascensia Diabetes Care US INC. | $42.44 | 2023-2024 | |
| Dexcom, INC. | $32.55 | 2022-2023 | Dexcom G6 Transmitter |
| Ascendis Pharma Endocrinology INC | $28.77 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $26.75 | 2025 | Twiist |
| Globus Medical, INC. | $24.92 | 2025 | Senza |
| Halozyme INC | $18.78 | 2023 | |
| Averitas Pharma INC. | $17.18 | 2023 | Qutenza |
| Renalytix Ai, INC. | $16.09 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Medtronic, INC. | $15.78 | 2023 | Minimed 780g |
| Ferring Pharmaceuticals INC. | $15.67 | 2019 | |
| Axonics, INC. | $13.53 | 2024 | Axonics |
| Medtronic Minimed, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.